Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property

WELLESLEY HILLS, Massachusetts, December 8 - Joseph F. Finn, Jr., C.P.A. Managing Partner of Finn, Warnke & Gayton
announced today that the firm is offering a sales platform for biotechnology
companies to sell their intellectual property. According to industry sources,
many of these enterprises have intellectual property sitting dormant in
various stages of development due to funding, scientific or regulatory
issues.

Finn noted that the firm's experience in selling the intellectual
property of ActivBiotics, Spherics, Prospect Therapeutics, Alpha Beta
Technologies and Epix Pharmaceuticals has given it the opportunity to develop
a database of active buyers and create a legal platform to conduct sales. It
has also created a steady flow of inquires from biotech firms and individuals
regarding the firm's future offerings of intellectual property.

Persons interested in discussing this service should contact Joseph F.
Finn, Jr., Christopher J. Finn, or Paul Bolger at +1-781-237-8840 or
jffinnjr@earthlink.net.

About Finn, Warnke & Gayton

For over 35 years, Finn, Warnke & Gayton has been one of the region's
most respected business consulting and accounting firms. In addition to our
new service, our team of professionals provides management consulting
services to distressed enterprises, accounting, trustee, and agency services
related to bankruptcy and insolvency matters, advisory services to financial
institutions, interim management, and traditional tax and accounting services
to corporations and individuals. For more information on the firm, please
visit our website at finnwarnkegayton.com.

Joseph F. Finn, Jr., jffinnjr at earthlink.net, Christopher J. Finn, or Paul Bolger, +1-781-237-8840